Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 1
2009 2
2010 4
2011 2
2012 3
2014 1
2020 2
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial.
Deodhar A, Helliwell PS, Boehncke WH, Kollmeier AP, Hsia EC, Subramanian RA, Xu XL, Sheng S, Agarwal P, Zhou B, Zhuang Y, Ritchlin CT; DISCOVER-1 Study Group. Deodhar A, et al. Among authors: subramanian ra. Lancet. 2020 Apr 4;395(10230):1115-1125. doi: 10.1016/S0140-6736(20)30265-8. Epub 2020 Mar 13. Lancet. 2020. PMID: 32178765 Free article. Clinical Trial.
Efficacy and Safety of Guselkumab, an Interleukin-23p19-Specific Monoclonal Antibody, Through One Year in Biologic-Naive Patients With Psoriatic Arthritis.
McInnes IB, Rahman P, Gottlieb AB, Hsia EC, Kollmeier AP, Chakravarty SD, Xu XL, Subramanian RA, Agarwal P, Sheng S, Jiang Y, Zhou B, Zhuang Y, van der Heijde D, Mease PJ. McInnes IB, et al. Among authors: subramanian ra. Arthritis Rheumatol. 2021 Apr;73(4):604-616. doi: 10.1002/art.41553. Epub 2021 Mar 17. Arthritis Rheumatol. 2021. PMID: 33043600 Clinical Trial.
Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experienced.
Ritchlin CT, Helliwell PS, Boehncke WH, Soriano ER, Hsia EC, Kollmeier AP, Chakravarty SD, Zazzetti F, Subramanian RA, Xu XL, Zuraw QC, Sheng S, Jiang Y, Agarwal P, Zhou B, Zhuang Y, Shawi M, Karyekar CS, Deodhar A. Ritchlin CT, et al. Among authors: subramanian ra. RMD Open. 2021 Feb;7(1):e001457. doi: 10.1136/rmdopen-2020-001457. RMD Open. 2021. PMID: 33568556 Free PMC article. Clinical Trial.
Griscelli syndrome: hemophagocytic lymphohistiocytosis with silvery hair.
Mahalingashetti PB, Krishnappa MH, Kalyan PS, Subramanian RA, Padhy S. Mahalingashetti PB, et al. Among authors: subramanian ra. J Lab Physicians. 2012 Jul;4(2):129-30. doi: 10.4103/0974-2727.105597. J Lab Physicians. 2012. PMID: 23436972 Free PMC article. No abstract available.
Transpositionally active episomal hAT elements.
O'Brochta DA, Stosic CD, Pilitt K, Subramanian RA, Hice RH, Atkinson PW. O'Brochta DA, et al. Among authors: subramanian ra. BMC Mol Biol. 2009 Dec 14;10:108. doi: 10.1186/1471-2199-10-108. BMC Mol Biol. 2009. PMID: 20003420 Free PMC article.
Novel influenza A(H1N1) virus among gravid admissions.
Miller AC, Safi F, Hussain S, Subramanian RA, Elamin EM, Sinert R. Miller AC, et al. Among authors: subramanian ra. Arch Intern Med. 2010 May 24;170(10):868-73. doi: 10.1001/archinternmed.2010.126. Arch Intern Med. 2010. PMID: 20498414
Leukocytosis as prognostic indicator of major injury.
Paladino L, Subramanian RA, Bonilla E, Sinert RH. Paladino L, et al. Among authors: subramanian ra. West J Emerg Med. 2010 Dec;11(5):450-5. West J Emerg Med. 2010. PMID: 21293764 Free PMC article.
Hermes transposon distribution and structure in Musca domestica.
Subramanian RA, Cathcart LA, Krafsur ES, Atkinson PW, O'Brochta DA. Subramanian RA, et al. J Hered. 2009 Jul-Aug;100(4):473-80. doi: 10.1093/jhered/esp017. Epub 2009 Apr 14. J Hered. 2009. PMID: 19366812 Free PMC article.
Lymphatic filariasis: A view at pathological diversity.
Mahalingashetti PB, Subramanian RA, Jayker SS, Vijay A. Mahalingashetti PB, et al. Among authors: subramanian ra. Trop Parasitol. 2014 Jul;4(2):128-32. doi: 10.4103/2229-5070.138544. Trop Parasitol. 2014. PMID: 25250237 Free PMC article.
18 results